THE USE OF CANNABIDIOL ASSOCIATED WITH PHYSIOTHERAPEUTIC TREATMENT IN PEOPLE WITH PARKINSON'S DISEASE: AN INTEGRATIVE REVIEW

Abstract

Parkinson's disease (PD) is a neurodegenerative condition that affects the central nervous system, causing motor and non-motor impairments that impact patients' quality of life. This study aimed to describe the effects of cannabidiol (CBD) associated with physiotherapy treatment in people with PD, through an integrative reading review. The research was carried out in the PubMed, SciELO, Medline and Google Scholar databases, using the descriptors related to PD, CBD and physiotherapy, considering articles published between 2014 and 2024. The results demonstrate that CBD, due to its anti-inflammatory and neuroprotective properties, can be effective in reducing tremors, muscle stiffness and pain, while physiotherapy contributes to improving mobility and functionality. However, the lack of standardization in CBD dosages and routes of administration, as well as the scarcity of robust clinical trials, highlights the need for more studies on the subject. It is concluded that the interaction of CBD with physiotherapy presents promising therapeutic potential for the management of PD, highlighting the relevance of professionals trained in the prescription and application of complementary therapies.